John P. Houston, MD, PhD
- 8Articles
- 21.5KReads
- 2006–2012Active
- 33Collaborators
- 157Citations
About
John P. Houston, MD, PhD, has published extensively on the pharmacogenomics and genetic associations related to treatment response in bipolar disorder and treatment-resistant depression. His work includes studies on olanzapine and its combination with other medications, focusing on weight gain, gene variants affecting drug efficacy, and suicide risk in bipolar I disorder. Houston's research spans clinical trials and genetic analyses addressing psychiatric medication outcomes.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
